Cart
sales@molnova.com
Cinacalcet metabolite M4
CAS No. 104774-87-0
Cinacalcet metabolite M4( Rarechem AL BW 1078 )
Catalog No. M26115 CAS No. 104774-87-0
Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 45 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 92 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 166 | In Stock |
|
| 200MG | 238 | In Stock |
|
| 500MG | 357 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCinacalcet metabolite M4
-
NoteResearch use only, not for human use.
-
Brief DescriptionCinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.
-
DescriptionCinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.
-
In Vitro——
-
In Vivo——
-
SynonymsRarechem AL BW 1078
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number104774-87-0
-
Formula Weight203.208
-
Molecular FormulaC10H12F3N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCCCc1cccc(c1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.J.L.M.Heeremans, et al. Interference of ?-amino-caproic acid with [N-succinimidyl S-acetylthioacetate derived] thiol-introduction into glu-plasminogen. Volume 8, Supplement 2, 1994, Pages 138-141.
molnova catalog
related products
-
Cis-22a
Cis-22a is a TRPV6 inhibitor (IC50 = 0.32 μM), which exhibits selectivity against related TRPV channels and calcium channels. cis-22a displays antiproliferative effects on T47D human breast cancer cells.
-
Azelnidipine
Azelnidipine is a dihydropyridine calcium channel blocker.
-
SR33805
SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively)Acute treatment with SR33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes.?
